Our Pricing

How Does Wegovy Work? Complete Dose Guide 0.25mg-2.4mg

Published on: June 03, 2026

Understanding how does Wegovy work UK is essential before starting treatment. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural gut hormones to reduce appetite and slow gastric emptying, helping patients achieve clinically significant weight loss when combined with lifestyle changes. At Cured Pharmacy, Wegovy is available from £79.00 with a free clinical assessment by UK-registered prescribers.

How Does Wegovy Work in the Body?

Wegovy works by activating GLP-1 (glucagon-like peptide-1) receptors in the brain, pancreas, and digestive system [1]. This naturally occurring hormone is released after eating and signals fullness to the brain whilst slowing how quickly food leaves the stomach. Semaglutide, the active ingredient in Wegovy, is a synthetic version that lasts much longer in the body than natural GLP-1.

In clinical trials, this mechanism produced substantial results. The STEP 1 trial demonstrated that patients using Wegovy 2.4mg weekly achieved an average 14.9% body weight reduction over 68 weeks, compared to 2.4% with placebo [1]. The medication doesn't burn fat directly—it reduces hunger signals and helps you feel satisfied with smaller portions, making it easier to maintain a reduced-calorie diet.

Wegovy also improves glycaemic control by stimulating insulin secretion when blood glucose is elevated and suppressing glucagon release. This dual action makes it particularly effective for patients with type 2 diabetes or prediabetes, though it's licensed specifically for chronic weight management in the UK [2].

Wegovy Dose Escalation Schedule: 0.25mg to 2.4mg

Wegovy follows a carefully designed dose escalation protocol over 16-20 weeks to minimise gastrointestinal side effects whilst building therapeutic effect. Your UK prescriber will start you at the lowest dose and gradually increase it monthly, subject to tolerability and clinical assessment.

The standard escalation schedule begins with 0.25mg once weekly for four weeks, then increases to 0.5mg weekly for four weeks, followed by 1mg weekly for four weeks, then 1.7mg weekly for four weeks, and finally the maintenance dose of 2.4mg weekly [3]. Each step allows your body to adapt to the medication, reducing the likelihood of nausea, vomiting, or diarrhoea.

If you experience persistent side effects at any dose, your prescriber may recommend staying at your current dose for an additional four weeks before escalating. Some patients achieve their weight loss goals at lower maintenance doses such as 1.7mg weekly, and this is entirely acceptable subject to clinical review [3].

What Happens If You Miss a Dose?

If you miss a Wegovy injection and it's been fewer than five days since your scheduled dose, take it as soon as you remember. If more than five days have passed, skip the missed dose and resume your normal schedule with the next injection. Never take two doses within 48 hours to catch up, as this significantly increases the risk of gastrointestinal side effects and doesn't improve efficacy.

Clinical Evidence: STEP Trial Results

The STEP (Semaglutide Treatment Effect in People with obesity) clinical trial programme provides robust evidence for Wegovy's efficacy. STEP 1 enrolled 1,961 adults with obesity or overweight plus weight-related comorbidities, demonstrating that 86.4% of participants on Wegovy 2.4mg achieved at least 5% weight loss, compared to 31.5% on placebo [1].

STEP 2 specifically studied patients with type 2 diabetes, showing an average 9.6% weight reduction with Wegovy versus 3.4% with placebo over 68 weeks [2]. This trial confirmed that semaglutide's dual benefits—glycaemic control and weight management—make it particularly valuable for this patient population.

Long-term data from STEP 4 evaluated weight maintenance after initial loss. Participants who continued Wegovy after 20 weeks lost an additional 7.9% body weight, whilst those switched to placebo regained 6.9%, demonstrating the importance of ongoing treatment for sustained results [4].

Real-World Effectiveness vs Clinical Trials

Clinical trial results represent ideal conditions with close monitoring and support. Real-world effectiveness may vary based on adherence, lifestyle modifications, and individual metabolic factors. UK prescribers at Cured Pharmacy assess your suitability and provide guidance on optimising treatment outcomes through dietary changes and physical activity alongside medication.

Common Side Effects and How to Manage Them

Gastrointestinal side effects are the most frequently reported with Wegovy, particularly during dose escalation. Nausea affects approximately 44% of patients, diarrhoea 30%, vomiting 24%, and constipation 24% in clinical trials [1]. These symptoms typically peak during the first few weeks after a dose increase and diminish as your body adapts.

To minimise nausea, eat smaller, more frequent meals rather than three large ones. Avoid high-fat, fried, or spicy foods, which can exacerbate symptoms. Stay well-hydrated and consider taking your injection before bedtime so peak nausea occurs whilst sleeping. If symptoms persist beyond two weeks at any dose, contact your prescriber to discuss whether slowing escalation is appropriate.

Rare but serious side effects include pancreatitis, gallbladder problems, and hypoglycaemia (particularly if you're taking other diabetes medications). Seek immediate medical attention if you experience severe abdominal pain, persistent vomiting, or signs of an allergic reaction. Your UK prescriber will review your full medical history during consultation to identify any contraindications.

Who Can Use Wegovy in the UK?

Wegovy is licensed in the UK for adults with a body mass index (BMI) of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or obstructive sleep apnoea [3]. NICE guidance recommends considering GLP-1 receptor agonists for weight management when lifestyle interventions alone haven't achieved adequate results.

The medication is contraindicated if you have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. It's also not recommended during pregnancy or breastfeeding. Your UK prescriber will assess your complete medical history, current medications, and treatment goals during your free consultation to determine suitability.

All Wegovy prescriptions at Cured Pharmacy require clinical assessment by a UK-registered prescriber. This ensures the treatment is appropriate for your individual circumstances and allows for proper monitoring throughout your weight loss journey. The consultation takes under three minutes and is completely free, with transparent pricing shown before you begin.

Age and Special Populations

Wegovy is licensed for adults aged 18 and over. Safety and efficacy haven't been established in patients over 75 years, though prescribers may consider it on a case-by-case basis. Patients with renal or hepatic impairment should discuss their condition during consultation, as dose adjustments may be necessary subject to clinical judgement.

How to Administer Wegovy Injections

Wegovy comes in a pre-filled, single-use injection pen designed for subcutaneous administration. You'll inject into the abdomen, thigh, or upper arm once weekly, on the same day each week regardless of meals. The pen is simple to use—attach a new needle, dial your dose (which is pre-set for each pen strength), insert the needle at a 90-degree angle, and press the button until you hear a click.

Rotate injection sites each week to prevent lipodystrophy (changes in fat tissue under the skin). If you inject in your abdomen on Monday, use your thigh the following Monday, then your upper arm the week after. Store unused pens in the refrigerator between 2°C and 8°C, but never freeze them. Once in use, pens can be kept at room temperature (up to 30°C) for up to 28 days.

Your first prescription from Cured Pharmacy includes detailed administration instructions and access to support from our UK-registered clinical team. If you're uncertain about injection technique or experience issues with your pen, contact us on (+44) 116 4646009 for guidance. Proper administration ensures optimal absorption and reduces the risk of injection site reactions.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Davies, M., Færch, L., Jeppesen, O. K., et al. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971–984. https://doi.org/10.1016/S0140-6736(21)00213-0 [accessed 13 August 2026]
3. Novo Nordisk. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Medicines and Healthcare products Regulatory Agency (MHRA). https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
4. Rubino, D., Abrahamsson, N., Davies, M., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Wegovy is a prescription-only medicine in the UK and must be prescribed following a clinical consultation with a registered healthcare professional. Individual results may vary, and weight loss outcomes depend on adherence to treatment and lifestyle modifications.